HARROW INC (HROW) Fundamental Analysis & Valuation

NASDAQ:HROW • US4158581094

Current stock price

33.875 USD
-1.51 (-4.25%)
Last:

This HROW fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. HROW Profitability Analysis

1.1 Basic Checks

  • HROW had positive earnings in the past year.
  • HROW had a positive operating cash flow in the past year.
  • In the past 5 years HROW always reported negative net income.
  • Of the past 5 years HROW 4 years had a positive operating cash flow.
HROW Yearly Net Income VS EBIT VS OCF VS FCFHROW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M

1.2 Ratios

  • The Return On Assets of HROW (-1.29%) is better than 77.72% of its industry peers.
  • HROW has a Return On Equity of -9.80%. This is in the better half of the industry: HROW outperforms 75.13% of its industry peers.
  • HROW has a Return On Invested Capital of 7.95%. This is amongst the best in the industry. HROW outperforms 87.05% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for HROW is significantly below the industry average of 13.06%.
  • The last Return On Invested Capital (7.95%) for HROW is above the 3 year average (3.53%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.29%
ROE -9.8%
ROIC 7.95%
ROA(3y)-4.53%
ROA(5y)-8.27%
ROE(3y)-23.13%
ROE(5y)-56.8%
ROIC(3y)3.53%
ROIC(5y)2.67%
HROW Yearly ROA, ROE, ROICHROW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300 -400

1.3 Margins

  • HROW has a Operating Margin of 11.21%. This is amongst the best in the industry. HROW outperforms 82.90% of its industry peers.
  • In the last couple of years the Operating Margin of HROW has grown nicely.
  • With an excellent Gross Margin value of 75.05%, HROW belongs to the best of the industry, outperforming 82.38% of the companies in the same industry.
  • In the last couple of years the Gross Margin of HROW has remained more or less at the same level.
Industry RankSector Rank
OM 11.21%
PM (TTM) N/A
GM 75.05%
OM growth 3Y72.93%
OM growth 5Y48.83%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.7%
GM growth 5Y1.28%
HROW Yearly Profit, Operating, Gross MarginsHROW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. HROW Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HROW is destroying value.
  • HROW has more shares outstanding than it did 1 year ago.
  • HROW has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for HROW is higher compared to a year ago.
HROW Yearly Shares OutstandingHROW Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
HROW Yearly Total Debt VS Total AssetsHROW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • HROW has an Altman-Z score of 3.01. This indicates that HROW is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.01, HROW is in the better half of the industry, outperforming 69.95% of the companies in the same industry.
  • The Debt to FCF ratio of HROW is 5.69, which is a neutral value as it means it would take HROW, 5.69 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of HROW (5.69) is better than 82.90% of its industry peers.
  • A Debt/Equity ratio of 4.64 is on the high side and indicates that HROW has dependencies on debt financing.
  • The Debt to Equity ratio of HROW (4.64) is worse than 80.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.64
Debt/FCF 5.69
Altman-Z 3.01
ROIC/WACC0.83
WACC9.6%
HROW Yearly LT Debt VS Equity VS FCFHROW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

2.3 Liquidity

  • HROW has a Current Ratio of 2.20. This indicates that HROW is financially healthy and has no problem in meeting its short term obligations.
  • HROW has a Current ratio (2.20) which is comparable to the rest of the industry.
  • HROW has a Quick Ratio of 2.06. This indicates that HROW is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 2.06, HROW perfoms like the industry average, outperforming 48.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 2.06
HROW Yearly Current Assets VS Current LiabilitesHROW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. HROW Growth Analysis

3.1 Past

  • HROW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 104.55%, which is quite impressive.
  • Looking at the last year, HROW shows a very strong growth in Revenue. The Revenue has grown by 36.41%.
  • Measured over the past years, HROW shows a very strong growth in Revenue. The Revenue has been growing by 40.99% on average per year.
EPS 1Y (TTM)104.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.17%
Revenue 1Y (TTM)36.41%
Revenue growth 3Y45.39%
Revenue growth 5Y40.99%
Sales Q2Q%33.31%

3.2 Future

  • Based on estimates for the next years, HROW will show a very strong growth in Earnings Per Share. The EPS will grow by 216.53% on average per year.
  • HROW is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 33.73% yearly.
EPS Next Y6823.25%
EPS Next 2Y1111.41%
EPS Next 3Y532.86%
EPS Next 5Y216.53%
Revenue Next Year30.6%
Revenue Next 2Y39.27%
Revenue Next 3Y38.84%
Revenue Next 5Y33.73%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
HROW Yearly Revenue VS EstimatesHROW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
HROW Yearly EPS VS EstimatesHROW Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. HROW Valuation Analysis

4.1 Price/Earnings Ratio

  • HROW is valuated quite expensively with a Price/Earnings ratio of 1693.75.
  • HROW's Price/Earnings ratio is a bit cheaper when compared to the industry. HROW is cheaper than 76.68% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, HROW is valued quite expensively.
  • The Price/Forward Earnings ratio is 24.46, which indicates a rather expensive current valuation of HROW.
  • Based on the Price/Forward Earnings ratio, HROW is valued a bit cheaper than the industry average as 74.61% of the companies are valued more expensively.
  • HROW's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.51.
Industry RankSector Rank
PE 1693.75
Fwd PE 24.46
HROW Price Earnings VS Forward Price EarningsHROW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 500 1K 1.5K

4.2 Price Multiples

  • 77.20% of the companies in the same industry are more expensive than HROW, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, HROW is valued cheaper than 81.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF 29.49
EV/EBITDA 30.1
HROW Per share dataHROW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • HROW's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • HROW has a very decent profitability rating, which may justify a higher PE ratio.
  • HROW's earnings are expected to grow with 532.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.25
PEG (5Y)N/A
EPS Next 2Y1111.41%
EPS Next 3Y532.86%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HROW Dividend Analysis

5.1 Amount

  • HROW does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HROW Fundamentals: All Metrics, Ratios and Statistics

HARROW INC

NASDAQ:HROW (3/27/2026, 11:15:29 AM)

33.875

-1.51 (-4.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-02
Earnings (Next)05-06
Inst Owners60.86%
Inst Owner Change5.3%
Ins Owners14.8%
Ins Owner Change2.47%
Market Cap1.26B
Revenue(TTM)272.30M
Net Income(TTM)-5.14M
Analysts85.71
Price Target72.13 (112.93%)
Short Float %17.32%
Short Ratio6.9
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-36.46%
Min EPS beat(2)-54.8%
Max EPS beat(2)-18.12%
EPS beat(4)1
Avg EPS beat(4)153.68%
Min EPS beat(4)-970.3%
Max EPS beat(4)1657.94%
EPS beat(8)3
Avg EPS beat(8)79.23%
EPS beat(12)3
Avg EPS beat(12)-68.6%
EPS beat(16)5
Avg EPS beat(16)-818.62%
Revenue beat(2)0
Avg Revenue beat(2)-2.98%
Min Revenue beat(2)-4.71%
Max Revenue beat(2)-1.25%
Revenue beat(4)0
Avg Revenue beat(4)-7.25%
Min Revenue beat(4)-17.73%
Max Revenue beat(4)-1.25%
Revenue beat(8)2
Avg Revenue beat(8)-3.16%
Revenue beat(12)4
Avg Revenue beat(12)-2.86%
Revenue beat(16)6
Avg Revenue beat(16)-1.85%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-187.37%
EPS NQ rev (3m)-187.37%
EPS NY rev (1m)-2.34%
EPS NY rev (3m)-3.72%
Revenue NQ rev (1m)-8.47%
Revenue NQ rev (3m)-8.47%
Revenue NY rev (1m)-8.15%
Revenue NY rev (3m)-7.19%
Valuation
Industry RankSector Rank
PE 1693.75
Fwd PE 24.46
P/S 4.63
P/FCF 29.49
P/OCF 28.75
P/B 24.05
P/tB N/A
EV/EBITDA 30.1
EPS(TTM)0.02
EY0.06%
EPS(NY)1.38
Fwd EY4.09%
FCF(TTM)1.15
FCFY3.39%
OCF(TTM)1.18
OCFY3.48%
SpS7.31
BVpS1.41
TBVpS-3.34
PEG (NY)0.25
PEG (5Y)N/A
Graham Number0.8
Profitability
Industry RankSector Rank
ROA -1.29%
ROE -9.8%
ROCE 10.07%
ROIC 7.95%
ROICexc 10.47%
ROICexgc 45.01%
OM 11.21%
PM (TTM) N/A
GM 75.05%
FCFM 15.7%
ROA(3y)-4.53%
ROA(5y)-8.27%
ROE(3y)-23.13%
ROE(5y)-56.8%
ROIC(3y)3.53%
ROIC(5y)2.67%
ROICexc(3y)4.56%
ROICexc(5y)4.34%
ROICexgc(3y)19.98%
ROICexgc(5y)16.24%
ROCE(3y)4.47%
ROCE(5y)3.38%
ROICexgc growth 3Y47.43%
ROICexgc growth 5Y53.72%
ROICexc growth 3Y36.57%
ROICexc growth 5Y20.03%
OM growth 3Y72.93%
OM growth 5Y48.83%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.7%
GM growth 5Y1.28%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 4.64
Debt/FCF 5.69
Debt/EBITDA 4.92
Cap/Depr 5.83%
Cap/Sales 0.4%
Interest Coverage 1.63
Cash Conversion 88.76%
Profit Quality N/A
Current Ratio 2.2
Quick Ratio 2.06
Altman-Z 3.01
F-Score6
WACC9.6%
ROIC/WACC0.83
Cap/Depr(3y)534.18%
Cap/Depr(5y)356.54%
Cap/Sales(3y)45.63%
Cap/Sales(5y)28.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)104.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.17%
EPS Next Y6823.25%
EPS Next 2Y1111.41%
EPS Next 3Y532.86%
EPS Next 5Y216.53%
Revenue 1Y (TTM)36.41%
Revenue growth 3Y45.39%
Revenue growth 5Y40.99%
Sales Q2Q%33.31%
Revenue Next Year30.6%
Revenue Next 2Y39.27%
Revenue Next 3Y38.84%
Revenue Next 5Y33.73%
EBIT growth 1Y232.7%
EBIT growth 3Y151.42%
EBIT growth 5Y109.84%
EBIT Next Year259.42%
EBIT Next 3Y93.43%
EBIT Next 5Y57.48%
FCF growth 1Y170.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y297.57%
OCF growth 3Y194.92%
OCF growth 5YN/A

HARROW INC / HROW Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HARROW INC?

ChartMill assigns a fundamental rating of 6 / 10 to HROW.


Can you provide the valuation status for HARROW INC?

ChartMill assigns a valuation rating of 6 / 10 to HARROW INC (HROW). This can be considered as Fairly Valued.


Can you provide the profitability details for HARROW INC?

HARROW INC (HROW) has a profitability rating of 6 / 10.


How financially healthy is HARROW INC?

The financial health rating of HARROW INC (HROW) is 5 / 10.


What is the expected EPS growth for HARROW INC (HROW) stock?

The Earnings per Share (EPS) of HARROW INC (HROW) is expected to grow by 6823.25% in the next year.